| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4303138 | Journal of Surgical Research | 2010 | 8 Pages |
Abstract
HS causes an acute rise in serum claudin-3 protein levels and a concurrent decrease in intestinal claudin-3 protein expression. VPA treatment attenuates these alterations and stabilizes intestinal claudin-3 levels. Our results demonstrate for the first time that claudin-3 is a potential biomarker in HS and treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Yongqing M.D., Ph.D., Baoling M.D., Simon T. Ph.D., Eugene Y. M.D., Tareq M.D., Elizabeth A. M.D., George M.D., Ph.D., Marc M.D., Towia A. Ph.D., Hasan B. M.D.,